Moberg Pharma AB (publ)
STO:MOB

Watchlist Manager
Moberg Pharma AB (publ) Logo
Moberg Pharma AB (publ)
STO:MOB
Watchlist
Price: 11.97 SEK -5.52%
Market Cap: 558.9m SEK
Have any thoughts about
Moberg Pharma AB (publ)?
Write Note

Moberg Pharma AB (publ)
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Moberg Pharma AB (publ)
Net Income Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
IRLAB A
I
FLERIE

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Moberg Pharma AB (publ)
STO:MOB
Net Income
-kr27.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Net Income
-kr353.1m
CAGR 3-Years
14%
CAGR 5-Years
-60%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Net Income
kr236.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Net Income
kr224.7m
CAGR 3-Years
24%
CAGR 5-Years
45%
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Net Income
-kr180.8m
CAGR 3-Years
-25%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Net Income
-kr204.8m
CAGR 3-Years
-43%
CAGR 5-Years
-23%
CAGR 10-Years
N/A

See Also

What is Moberg Pharma AB (publ)'s Net Income?
Net Income
-27.5m SEK

Based on the financial report for Dec 31, 2023, Moberg Pharma AB (publ)'s Net Income amounts to -27.5m SEK.

What is Moberg Pharma AB (publ)'s Net Income growth rate?
Net Income CAGR 1Y
-36%

Over the last year, the Net Income growth was -36%.

Back to Top